These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 2143325)
1. Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure. Gajewski JL; Ho WG; Feig SA; Hunt L; Kaufman N; Champlin RE Transplantation; 1990 Aug; 50(2):244-9. PubMed ID: 2143325 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428 [TBL] [Abstract][Full Text] [Related]
4. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826 [TBL] [Abstract][Full Text] [Related]
5. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Casper J; Camitta B; Truitt R; Baxter-Lowe LA; Bunin N; Lawton C; Murray K; Hunter J; Pietryga D; Garbrecht F Blood; 1995 May; 85(9):2354-63. PubMed ID: 7727769 [TBL] [Abstract][Full Text] [Related]
6. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. Laughlin MJ; Eapen M; Rubinstein P; Wagner JE; Zhang MJ; Champlin RE; Stevens C; Barker JN; Gale RP; Lazarus HM; Marks DI; van Rood JJ; Scaradavou A; Horowitz MM N Engl J Med; 2004 Nov; 351(22):2265-75. PubMed ID: 15564543 [TBL] [Abstract][Full Text] [Related]
7. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y; Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690 [TBL] [Abstract][Full Text] [Related]
8. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Wagner JE; Rosenthal J; Sweetman R; Shu XO; Davies SM; Ramsay NK; McGlave PB; Sender L; Cairo MS Blood; 1996 Aug; 88(3):795-802. PubMed ID: 8704232 [TBL] [Abstract][Full Text] [Related]
9. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
10. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. Kernan NA; Bartsch G; Ash RC; Beatty PG; Champlin R; Filipovich A; Gajewski J; Hansen JA; Henslee-Downey J; McCullough J N Engl J Med; 1993 Mar; 328(9):593-602. PubMed ID: 8429851 [TBL] [Abstract][Full Text] [Related]
11. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959 [TBL] [Abstract][Full Text] [Related]
12. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Anasetti C; Beatty PG; Storb R; Martin PJ; Mori M; Sanders JE; Thomas ED; Hansen JA Hum Immunol; 1990 Oct; 29(2):79-91. PubMed ID: 2249952 [TBL] [Abstract][Full Text] [Related]
13. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Hows JM; Yin JL; Marsh J; Swirsky D; Jones L; Apperley JF; James DC; Smithers S; Batchelor JR; Goldman JM Blood; 1986 Dec; 68(6):1322-8. PubMed ID: 3535929 [TBL] [Abstract][Full Text] [Related]
14. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120 [TBL] [Abstract][Full Text] [Related]
15. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Shaw PJ; Kan F; Woo Ahn K; Spellman SR; Aljurf M; Ayas M; Burke M; Cairo MS; Chen AR; Davies SM; Frangoul H; Gajewski J; Gale RP; Godder K; Hale GA; Heemskerk MB; Horan J; Kamani N; Kasow KA; Chan KW; Lee SJ; Leung WH; Lewis VA; Miklos D; Oudshoorn M; Petersdorf EW; Ringdén O; Sanders J; Schultz KR; Seber A; Setterholm M; Wall DA; Yu L; Pulsipher MA Blood; 2010 Nov; 116(19):4007-15. PubMed ID: 20671124 [TBL] [Abstract][Full Text] [Related]
17. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255 [TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia. Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460 [TBL] [Abstract][Full Text] [Related]
19. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Szydlo R; Goldman JM; Klein JP; Gale RP; Ash RC; Bach FH; Bradley BA; Casper JT; Flomenberg N; Gajewski JL; Gluckman E; Henslee-Downey PJ; Hows JM; Jacobsen N; Kolb HJ; Lowenberg B; Masaoka T; Rowlings PA; Sondel PM; van Bekkum DW; van Rood JJ; Vowels MR; Zhang MJ; Horowitz MM J Clin Oncol; 1997 May; 15(5):1767-77. PubMed ID: 9164184 [TBL] [Abstract][Full Text] [Related]
20. Treatment of leukemia with partially matched related bone marrow transplantation. Munn RK; Henslee-Downey PJ; Romond EH; Marciniak EJ; Fleming DR; Messino MJ; Macdonald JS; Rayens MK; Harder EJ; Phillips GL; Thompson JS Bone Marrow Transplant; 1997 Mar; 19(5):421-7. PubMed ID: 9052906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]